Cargando…
PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The progra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319490/ https://www.ncbi.nlm.nih.gov/pubmed/28207501 http://dx.doi.org/10.1097/MD.0000000000005730 |
_version_ | 1782509389360398336 |
---|---|
author | Crescenzi, Anna Taffon, Chiara Donati, Michele Guarino, Michele Pier Luca Valeri, Sergio Coppola, Roberto |
author_facet | Crescenzi, Anna Taffon, Chiara Donati, Michele Guarino, Michele Pier Luca Valeri, Sergio Coppola, Roberto |
author_sort | Crescenzi, Anna |
collection | PubMed |
description | INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The programmed death 1–programmed death-ligand 1 (PD-1/PD-L1) axis has recently emerged as a master immune checkpoint that controls antitumor immune responses against many neoplasms. PATIENT'S CONCERNS CASE STUDY AND OUTCOME: We report the case of a male patient with gastric carcinoma with lymphoid stroma with a large mass infiltrating the gastric wall without nodal metastasis. He is alive without disease 10 months after surgery. We focused the study on factors that potentially modulate the prognosis. In this setting we demonstrate, for the first time in this type of tumor, by immunohistochemistry a strong PD-L1 expression in neoplastic cell and the presence of PD-1 positive infiltrating lymphocytes. CONCLUSION: The applied approach may contribute to the knowledge about host reaction in such tumor and it may also be used for tumor precise identification on the endoscopic biopsy time before excision surgery. |
format | Online Article Text |
id | pubmed-5319490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-53194902017-03-02 PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study Crescenzi, Anna Taffon, Chiara Donati, Michele Guarino, Michele Pier Luca Valeri, Sergio Coppola, Roberto Medicine (Baltimore) 4500 INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The programmed death 1–programmed death-ligand 1 (PD-1/PD-L1) axis has recently emerged as a master immune checkpoint that controls antitumor immune responses against many neoplasms. PATIENT'S CONCERNS CASE STUDY AND OUTCOME: We report the case of a male patient with gastric carcinoma with lymphoid stroma with a large mass infiltrating the gastric wall without nodal metastasis. He is alive without disease 10 months after surgery. We focused the study on factors that potentially modulate the prognosis. In this setting we demonstrate, for the first time in this type of tumor, by immunohistochemistry a strong PD-L1 expression in neoplastic cell and the presence of PD-1 positive infiltrating lymphocytes. CONCLUSION: The applied approach may contribute to the knowledge about host reaction in such tumor and it may also be used for tumor precise identification on the endoscopic biopsy time before excision surgery. Wolters Kluwer Health 2017-02-17 /pmc/articles/PMC5319490/ /pubmed/28207501 http://dx.doi.org/10.1097/MD.0000000000005730 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 4500 Crescenzi, Anna Taffon, Chiara Donati, Michele Guarino, Michele Pier Luca Valeri, Sergio Coppola, Roberto PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title | PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title_full | PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title_fullStr | PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title_full_unstemmed | PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title_short | PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
title_sort | pd-l1/pd-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319490/ https://www.ncbi.nlm.nih.gov/pubmed/28207501 http://dx.doi.org/10.1097/MD.0000000000005730 |
work_keys_str_mv | AT crescenzianna pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy AT taffonchiara pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy AT donatimichele pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy AT guarinomichelepierluca pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy AT valerisergio pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy AT coppolaroberto pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy |